Jul 10, 2019

Veramaris opens US$200m facility for EPA & DHA omega-3 algal oil to support sustainable growth in aquaculture

  • Veramaris opens its Blair, Nebraska facility, a breakthrough in cultivating marine algae naturally rich in EPA and DHA omega-3 at an unprecedented scale

  • The Veramaris algal oil enables salmon farmers to become net fish producers (FFDR < 1), while reversing the decade-long decline of EPA & DHA omega-3 levels in salmon.

  • The aquaculture industry is able to reduce its reliance on the unpredictable forage fisheries facing increasing pressure, and contribute to the UN’s sustainable development goal #14 (FAO 2018).
From left to right:
Johann-Caspar Gammelin (Chairman of the Board of Management Evonik Nutrition & Care), Christian Kullmann (CEO Evonik), Neil Leininger (General Manager Veramaris LLC), Nebraska Governor Pete Ricketts, Karim Kurmaly (CEO Veramaris),
The new Veramaris facility for the production of omega-3 EPA & DHA from natural marine algae in Blair, Nebraska.
The new Veramaris facility for the production of omega-3 EPA & DHA from natural marine algae in Blair, Nebraska.
The new Veramaris facility for the production of omega-3 EPA & DHA from natural marine algae in Blair, Nebraska.
Work in the laboratories at the Veramaris facility in Blair, Nebraska.
Work in the laboratories at the Veramaris facility in Blair, Nebraska.
Work in the laboratories at the Veramaris facility in Blair, Nebraska.

Veramaris has started commercial scale deliveries of its algal oil, meaning that fish oil is no longer a limiting factor for the further growth in aquaculture. The Veramaris oil is a scalable and reliable alternative source of EPA and DHA, the two marine omega-3 fatty acids proven to be essential for good health, for both fish and humans.

The zero-waste facility in Blair, Nebraska, USA was completed in May ahead of schedule, on budget and with zero-accidents. Next step is ramp up for full production.

Breakthrough innovation for the aquaculture industry

Veramaris runs its innovative US$200 million facility with proprietary technology. The intellectual property behind the production technology, the algae strain Schizochytrium ssp. and the downstream processes are all strongly protected by patents.

This unique strain of natural marine algae is rich in both EPA and DHA, and together with the technology to cultivate it at a very large scale, is a breakthrough that expands the future supply of healthy seafood without impacting ocean resources.

The levels of EPA and DHA omega-3 in farmed salmon have declined significantly over the past ten years. Veramaris’ algal oil, contains twice as much EPA and DHA as fish oil, so it can reverse the decline, and support the salmon brand-promise for healthy nutrition. This is also good news for the health and robustness of the salmon itself.

Due to its state-of-the-art fermentation process, the Veramaris algal oil is free from sea-borne contaminants and unique for its pristine quality 365 days a year. The full traceability of the raw materials used, and the transparent production process provide peace of mind for the consumer.

Consumer research data (Veramaris Market Data 2016 & 2018) show that omega-3 fatty acids are very important to salmon consumers in all of the surveyed countries, including the US, UK and France. Consumers care about healthy and sustainably raised seafood. In particular, the research found that frequent buyers of salmon are even more aware of the current state of the oceans.

A significant contribution to conserving marine biodiversity

In response to the aquaculture industry’s call for novel and sustainable sources of EPA and DHA, Veramaris’ production capacity is equivalent to 1.2 million tons of wild-catch fish. This will meet around 15 percent of the entire salmon farming industry's annual demand for EPA and DHA – providing a significant contribution to conserving the biodiversity in our oceans and reducing pressure on marine wild catch fisheries.

Veramaris celebrated the opening of its new facility in the presence of Nebraska Governor Pete Ricketts, local authorities, Feike Sijbesma and Christian Kullmann, the CEOs of the Veramaris parent companies DSM and Evonik, guests and staff in a ceremony at the site on 10 July 2019.

Veramaris Media contacts

Johan Brouwer

Images for download

Follow us on

About Veramaris

Veramaris, headquartered in Delft, The Netherlands, is a joint venture between DSM and Evonik, both world leaders in science and specialty chemicals. Established in 2018, Veramaris was formed to help realise a vision to conserve natural marine life by using the ocean's own resource, natural marine algae, to sustainably expand the world's access to Omega-3.

Veramaris extracts oil from natural marine algae, rich in both the essential Omega-3 fatty acids EPA & DHA, and also ARA, a long chain Omega-6, vital nutrients for improved brain, heart and eye health in both animals and humans.

The zero-waste industrial scale production process runs at a state-of-the-art site in Blair, Nebraska, USA.

Veramaris enables key stakeholders in aquaculture and pet nutrition to become independent of wild-caught fish and meet the growing demand for sustainable seafood and animal protein.

Legal Disclaimer

This information and any recommendations, technical or otherwise, are presented in good faith and believed to be correct as of the date prepared. Recipients of this information and recommendations must make their own determination as to its suitability for their purposes. VERAMARIS EXPRESSLY DISCLAIMS ANY REPRESENTATIONS AND WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED, AS TO THE ACCURACY, RELIABILITY, COMPLETENESS, NON-INFRINGEMENT, MERCHANTABILITY AND/OR FITNESS FOR A PARTICULAR PURPOSE (EVEN IF VERAMARIS IS AWARE OF SUCH PURPOSE) WITH RESPECT TO ANY INFORMATION AND RECOMMENDATIONS PROVIDED. IN NO EVENT SHALL VERAMARIS BE LIABLE FOR ANY DAMAGES ARISING FROM OR RELIANCE UPON, OR USE OF, ANY INFORMATION OR RECOMMENDATIONS PROVIDED HEREIN. Reference to any trade names used by other companies is neither a recommendation nor an endorsement of the corresponding product and does not imply that similar products could not be used. Veramaris reserves the right to make any changes to the information and/or recommendations at any time, without prior or subsequent notice.

Go back

Newsroom overview